Evidence Gaps in Clinical Trials of Pharmacologic Treatment for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Future Perspectives.

导出 OA

翻译打印收藏纠错

第一作者： Surapon,Nochaiwong

第一单位： Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.;Pharmacoepidemiology and Statistics Research Center (PESRC), Chiang Mai University, Chiang Mai 50200, Thailand.

作者： Surapon,Nochaiwong ^[1] ; Mati,Chuamanochan ^[2] ; Chidchanok,Ruengorn ^[1] ; Kednapa,Thavorn ^[3]

作者单位： Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.;Pharmacoepidemiology and Statistics Research Center (PESRC), Chiang Mai University, Chiang Mai 50200, Thailand. ^[1] Pharmacoepidemiology and Statistics Research Center (PESRC), Chiang Mai University, Chiang Mai 50200, Thailand.;Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand. ^[2] Pharmacoepidemiology and Statistics Research Center (PESRC), Chiang Mai University, Chiang Mai 50200, Thailand.;Ottawa Hospital Research Institute, Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.;School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON K1G 5Z3, Canada. ^[3]

关键词 H1-antihistamine-refractory biologic agents chronic spontaneous urticaria clinical trials core outcomes sets evidence gaps minority groups

DOI 10.3390/ph15101246

PMID 36297357

发布时间 2022-10-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交